• vcard
D 314.552.6876
F 314.754.8390
  • Education
    • LL.M., Washington University in St. Louis
    • J.D., Washington University in St. Louis
    • B.A., Knox College
Andrew Hoyne practices business and corporate law focused upon the representation of life sciences and other technology-based companies. His clients include/have included multi-billion dollar corporations, Big Ten universities, emerging companies and investors. Andy's life science practice includes pharmaceuticals, medical devices, research services, chemical and biochemical products, agriculture, and bio-energy clients. He has also represented clients in the fields of energy; information technology; food products, ingredients and flavors; electric motors; imaging devices; powders for industrial applications; spectroscopic analytical technology; and other technical and industrial applications.

Prior to entering private practice, Andy was associate general counsel for Invitron, a publicly-held biopharmaceutical contract manufacturing and product development company, and assistant general counsel for The Seven-Up Company, a soft drink and food products company.

From 2011-2015, Andy was the practice leader for the Startup Ventures practice segment in Polsinelli’s St. Louis office. He also served as one of the co-leaders of the firm’s national Startup Ventures practice segment.
Mr. Hoyne has represented clients in transactions totaling hundreds of millions of dollars.

He has represented clients in a wide range of life sciences projects representing emerging companies, established companies and research institutions. This experience includes representing clients in partnering agreements with Monsanto, Zimmer, Sangamo, Phillips, Bristol-Myers Squibb, Introgen, Viasys, and other companies and client exits to Monsanto and Avant Pharmaceuticals.  Matters include the following:
  • An ag-bio company, from start-up, through multiple rounds of venture financing and a $71 million sale to a major public corporation
  • An ag-bio company in a collaborative research and license agreement with a major public corporation relating to nematode resistant crops
  • A major public corporation in a strategic alliance with a public life sciences company valued at approximately $35 million focused upon zinc finger proteins
  • A major public corporation in multiple contracts and licensing agreements including in the field of RNAi
  • An emerging targeted molecular imaging company, in a partnering transaction with a major public corporation in the development and commercialization of novel molecular imaging agents
  • An emerging targeted molecular imaging company in a product development agreement with a major public corporation
  • An emerging orthobiologics company, in a strategic partnership with a major public corporation with respect to the development and commercialization of allograft tissue
  • An emerging anti-cancer company in a collaboration and license agreement with a public corporation
  • An emerging brain-wave company in a partnering agreement with a public corporation
  • An emerging human and animal vaccines company in its sale to a public corporation
  • The medical device arm of a major public corporation in the $85 million acquisition of a medical device business from a major public corporation
  • Multiple life science clients in over $100 million of venture capital funding from venture capital funds, angels, angel networks, corporations, state agencies, and regional accelerators
  • Multiple emerging and major corporate clients in multiple life sciences license, master service, confidentiality, manufacturing, research, collaboration, distribution, clinical study, and other agreements
Publication and Presentations Icon Publications & Presentations
Plan for Funding
Missouri Venture Forum 
Panel Moderator
June 13, 2016
Publication and Presentations Icon Publications & Presentations
Corporate Partnering
Center for Emerging Technologies
Program coordinator and moderator
December 11, 2013
Publication and Presentations Icon Publications & Presentations
Current Funding for Emerging Technology Companies
Missouri Venture Forum
November 21, 2013
Publication and Presentations Icon Publications & Presentations
JOBS Act
St. Louis Business Journal Program
October 30, 2013
Publication and Presentations Icon Publications & Presentations
Corporate Partnering
Licensing Executives Society, St. Louis Chapter
September 20, 2013
Publication and Presentations Icon Publications & Presentations
JOBS Act
Center for Emerging Technologies
August 29, 2013
Publication and Presentations Icon Publications & Presentations
JOBS Act
St. Louis Arch Angels
August 28, 2013
Publication and Presentations Icon Publications & Presentations
Starting a Technology Company
Washington University School of Engineering Faculty
August 26, 2013
Publication and Presentations Icon Publications & Presentations
Advanced Technology Transfer
Center for Emerging Technologies
Program Coordinator and Moderator; St. Louis
May 15, 2013
Publication and Presentations Icon Publications & Presentations
Avoiding Common Mistakes When Starting Your First Company; Raising Capital and Negotiating Terms
The Medical Entrepreneur Symposium 2013
Presentation given in Delray Beach, Florida
April 20, 2013
Related News


Past Events